可注射的菌体载微粒有效释放菌体,杀死耐美西林的金黄色葡萄球菌
Yajing Xu1, Tao Yang1, Yao Miao1
1School of Materials Science and Engineering, Zhejiang University, Hangzhou 310058, Zhejiang, China.
ACS applied materials & interfaces
|March 30, 2024
概括
菌体载微粒为对抗抗生素耐药细菌提供了一种新的方法. 这些微粒有效地将溶性菌体传递到感染部位,减少细菌负载并证明生物相容性.
科学领域:
- 生物技术是生物技术.
- 传染性疾病 传染性疾病
- 材料科学 材料科学 材料科学
背景情况:
- 细菌的多药抗生素耐药性构成了严重的公共卫生威胁.
- 菌体是传统抗生素的一个有希望的替代品.
- 需要有效的菌体治疗输送系统.
研究的目的:
- 开发可注射的菌体载微粒 (Phage-MPs),用于菌体的向输送和受控释放.
- 为了评估Phage-MPs对抗抗甲素耐药黄金葡萄球菌 (MRSA) 感染的疗效.
- 评估虫-MPs的生物分布和生物相容性.
主要方法:
- 菌体被静电连接到多孔的聚乙烯胺修饰丝纤维素微粒 (SF-MPs).
- 确定了体的载荷能力.
- 实验室和体内研究使用小鼠腹部MRSA感染模型进行.
- 评估了抗菌活性,菌体释放特征,生物分布和生物相容性.
主要成果:
- SF-MPs有效地加载了菌体,实现了高菌体载荷能力.
- 菌体-MPs显示了受控的菌体释放和强大的抗菌活性对抗MRSA.
- 与自由菌体相比,菌体MPs的内注射导致了持续的局部菌体度.
- 菌素-MPs显著降低了受感染器官中的细菌负载,并且在体外和体外表现出极好的生物相容性.
结论:
- 菌体载微粒是一种可行的策略,用于输送溶性菌体来对抗抗生素耐药的细菌感染.
- 这种新型的输送系统通过确保持续的局部菌体度来提高治疗疗效.
- 菌体MPs显示出新一代菌体抗菌疗法的潜力.
相关概念视频
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...